NORTHEAST PHARMACEUTICAL GROUP CO., LTD.

News Northeast Pharmaceutical Group Co., Ltd.

Stocks

000597

CNE0000009G0

Pharmaceuticals

End-of-day quote Shenzhen S.E. 2026-10-29			5-day change	1st Jan Change
4.330 ^CNY	-1.59%		-3.56%	-17.05%

10-28	Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2026	CI
08-24	Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

All News

Mentions Relevance

10-28	Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2026	CI
08-24	Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
06-15	Northeast Pharmaceutical Group Co., Ltd. Announces Final Cash Dividend on A Shares for 2025, Payable on 23 June 2026	CI
04-27	Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-02	Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
04-01	Northeast Pharmaceutical Group Co., Ltd. announces Annual dividend, payable on June 23, 2026	CI
25-10-27	Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025	CI
25-10-09	Northeast Pharmaceutical Unit Gets Clinical Trial Approval for Glioma Treatment	MT
25-09-08	Northeast Pharmaceutical Appoints CFO	MT
25-09-02	Northeast Pharmaceutical CFO Resigns	MT
25-08-26	Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025	CI
25-06-05	Northeast Pharmaceutical Gets Nod to Market Antiobiotic in Europe	MT
25-04-28	Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
25-04-25	Northeast Pharmaceutical Group Co., Ltd. Announces Directorate Appointments	CI
25-04-25	Northeast Pharmaceutical Group Co., Ltd. Approves Cash Dividend on (A Shares) for 2024, Payable on 23 June 2025	CI
25-04-17	Northeast Pharmaceutical's Subsidiary Gets Nod to Market Levocarnitine Oral Solution	MT
25-04-03	Northeast Pharmaceutical Group Co., Ltd. Proposes Final Cash Dividend for the Year 2024	CI
25-04-02	Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25-02-17	Northeast Pharmaceutical Gets Nod to Market HIV Raw Drug Material	MT
25-01-22	Northeast Pharmaceutical Group Names Chair	MT
25-01-09	Northeast Pharma to Donate 10 Million Yuan in Goods to Tibet's Earthquake Victims	MT
24-12-19	Northeast Pharmaceutical Gets Nod to Market Empagliflozin	MT
24-11-18	Northeast Pharmaceutical Group Co., Ltd. Completed the acquisition of 70% stake in Beijing Dingcheng Taiyuan Biotechnology Co., Ltd. from Zhang Rong and others.	CI
24-11-06	Northeast Pharmaceutical Group Acquiring 70% Stake in Dingcheng Peptide Source; Shares Up 10%	MT
24-10-23	Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024	CI